Volume 22, Issue 2 - Medical Writing Around the World
Regulatory medical writing in Switzerland
Author: Raquel Billiones
Abstract
Switzerland is practically unknown in the drug/medical device regulatory landscape despite being home to some of the world's biggest pharmaceutical firms. This article briefly describes the regulations governing clinical trials in Switzerland and cites examples of Swiss-specific regulatory documents.
Download the full article
References
- Verordnung über klinische Versuche mit Heilmitteln (VKlin) [2001 Oct 17] Available from: http://www.admin.ch/ch/d/sr/812_214_2/index.html
- Swissmedic Information Sheet FAQ [2012 Dec]. Available from: http://www.swissmedic.ch/bewilligungen/00089/00282/index.html
- Bundesgesetz über die Forschung am Menschen (Humanforschungsgesetz, HFG) [30 Sept 2011]. Available from: http://www.admin.ch/ch/d/ff/2011/7415.pdf
Visit the EMWA website
Search
Articles
Member Login
Links
Editoral Board
Editor-in-Chief
Co-Editors
Managing Editor
Victoria White
Deputy Managing Editor
Alicia Waltman
Associate Editors
Section Editors
Biotechnology
Digital Communication
EMWA News
Getting Your Foot in the Door
Good Writing Practice
Alison McIntosh / Stephen Gilliver
In the Bookstores
Manuscript Writing
Medical Communications/Writing for Patients
Medical Devices
My First Medical Writing
News from the EMA
Out on Our Own
Pharmacovigilance
Regulatory Matters
Regulatory Public Disclosure
Teaching Medical Writing
The Crofter: Sustainable Communications
Veterinary Writing
Editors Emeritus
Lay out Designer
Chris Monk